Antiemetic Studies on the NK1 Receptor Antagonist Aprepitant

Author： Stoutenburg John P.   Raftopoulos Harry  

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.2, Iss.5, 2004-09, pp. : 491-497

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aprepitant – a novel NK1-receptor antagonist

By Patel Lisa   Lindley Celeste  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2279-2296

Informa Healthcare

Access to resources Recommend Favorite

The neurokinin1 receptor antagonist aprepitant as an antiemetic for moderately emetogenic chemotherapy

By Warr David  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. : 1653-1658

Informa Healthcare

Access to resources Recommend Favorite

Antiemetic effects of sendide, a peptide tachykinin NK 1 receptor antagonist, in the ferret

By Minami M.   Endo T.   Kikuchi K.   Ihira E.   Hirafuji M.   Hamaue N.   Monma Y.   Sakurada T.   Tan-no K.   Kisara K.  

European Journal of Pharmacology, Vol. 363, Iss. 1, 1998-12 ,pp. : 49-55

Elsevier

Access to resources Recommend Favorite

Antiemetic effect of a tachykinin NK 1 receptor antagonist GR205171 on cisplatin-induced early and delayed emesis in the pigeon

By Tanihata S.   Oda S.   Kakuta S.   Uchiyama T.  

European Journal of Pharmacology, Vol. 461, Iss. 2, 2003-02 ,pp. : 197-206

Elsevier

Access to resources Recommend Favorite

Broad spectrum antiemetic effects of CP-122,721, a tachykinin NK 1 receptor antagonist, in ferrets

By Gonsalves S.   Watson J.   Ashton C.  

European Journal of Pharmacology, Vol. 305, Iss. 1, 1996-06 ,pp. : 181-185

Elsevier

Access to resources Recommend Favorite